Stocktoria
Tevogen Bio Holdings Inc. TVGN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-11-04
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Operating income | -$26.1M | -$53.6M | -$8.8M | — |
| Net income | -$26.3M | -$13.7M | -$60.5M | $4.4M |
| Operating cash flow | -$12.3M | -$12.0M | -$8.2M | -$215,395 |
| Free cash flow | -$12.4M | — | -$8.3M | — |
| Total assets | $4.4M | $3.5M | $5.5M | $357.1M |
| Total liabilities | $12.6M | $10.1M | $99.9M | $15.1M |
| Shareholders' equity | -$8.2M | -$6.7M | -$94.4M | -$34.0M |
| Ratios | ||||
| Return on assets | -599.5% | -396.6% | -1098.5% | 1.2% |
| Return on equity | 319.1% | 205.7% | 64.0% | -13.0% |
| Current ratio | 0.22 | 0.26 | 0.02 | 0.78 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001860871 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.